Literature DB >> 10852837

Dopamine function in Lesch-Nyhan disease.

W L Nyhan1.   

Abstract

Lesch-Nyhan disease is a disorder of purine metabolism resulting from mutations in the gene for hypoxanthine guanine phosphoribosyl transferase on the X chromosome. It is characterized by hyperuricemia and all of its consequences, as in gout; but in addition, patients have impressive disease of the central nervous system. This includes spasticity, involuntary movements, and retardation of motor development. The behavioral phenotype is best remembered by self-injurious biting behavior with attendant destruction of tissue. The connection between aberrant metabolism of purines and these neurologic and behavioral features of the disease is not clear. Increasing evidence points to imbalance of neurotransmitters. There is increased excretion of the serotonin metabolite 5-hydroxyindoleacetic acid in the urine. There are decreased quantities and activities of a number of dopaminergic functions. Positron emission tomography scanning has indicated deficiency in the dopamine transporter.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10852837      PMCID: PMC1637829          DOI: 10.1289/ehp.00108s3409

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  12 in total

1.  A FAMILIAL DISORDER OF URIC ACID METABOLISM AND CENTRAL NERVOUS SYSTEM FUNCTION.

Authors:  M LESCH; W L NYHAN
Journal:  Am J Med       Date:  1964-04       Impact factor: 4.965

Review 2.  Dopamine receptors: molecular structure and function.

Authors:  H B Niznik
Journal:  Mol Cell Endocrinol       Date:  1987-11       Impact factor: 4.102

3.  Presynaptic dopaminergic deficits in Lesch-Nyhan disease.

Authors:  M Ernst; A J Zametkin; J A Matochik; D Pascualvaca; P H Jons; K Hardy; J G Hankerson; D J Doudet; R M Cohen
Journal:  N Engl J Med       Date:  1996-06-13       Impact factor: 91.245

Review 4.  Heterotrimeric G proteins: organizers of transmembrane signals.

Authors:  E J Neer
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

5.  Serotonergic approaches to the modification of behavior in the Lesch-Nyhan Syndrome.

Authors:  W L Nyhan; H G Johnson; I A Kaufman; K L Jones
Journal:  Appl Res Ment Retard       Date:  1980

6.  Lesch-Nyhan syndrome: CSF neurotransmitter abnormalities.

Authors:  F S Silverstein; M V Johnston; R J Hutchinson; N L Edwards
Journal:  Neurology       Date:  1985-06       Impact factor: 9.910

7.  Effects of L-5-hydroxytryptophan on monoamine and amino acids turnover in the Lesch-Nyhan syndrome.

Authors:  S Castells; C Chakrabarti; B G Winsberg; M Hurwic; J M Perel; W L Nyhan
Journal:  J Autism Dev Disord       Date:  1979-03

8.  Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome.

Authors:  K G Lloyd; O Hornykiewicz; L Davidson; K Shannak; I Farley; M Goldstein; M Shibuya; W N Kelley; I H Fox
Journal:  N Engl J Med       Date:  1981-11-05       Impact factor: 91.245

9.  Acute basal ganglia infarction in propionic acidemia.

Authors:  R H Haas; D L Marsden; S Capistrano-Estrada; R Hamilton; M R Grafe; W Wong; W L Nyhan
Journal:  J Child Neurol       Date:  1995-01       Impact factor: 1.987

10.  Dystonia with motor delay in compound heterozygotes for GTP-cyclohydrolase I gene mutations.

Authors:  Y Furukawa; S J Kish; E M Bebin; R D Jacobson; J S Fryburg; W G Wilson; M Shimadzu; K Hyland; J M Trugman
Journal:  Ann Neurol       Date:  1998-07       Impact factor: 10.422

View more
  16 in total

1.  Adenosine, dopamine and serotonin receptors imbalance in lymphocytes of Lesch-Nyhan patients.

Authors:  Marta G García; Juan G Puig; Rosa J Torres
Journal:  J Inherit Metab Dis       Date:  2012-03-09       Impact factor: 4.982

Review 2.  Convergent mechanisms in etiologically-diverse dystonias.

Authors:  Valerie B Thompson; H A Jinnah; Ellen J Hess
Journal:  Expert Opin Ther Targets       Date:  2011-12-03       Impact factor: 6.902

3.  Regional brain volume abnormalities in Lesch-Nyhan disease and its variants: a cross-sectional study.

Authors:  David J Schretlen; Mark Varvaris; Tiffany E Ho; Tracy D Vannorsdall; Barry Gordon; James C Harris; H A Jinnah
Journal:  Lancet Neurol       Date:  2013-12       Impact factor: 44.182

4.  Altered gastrointestinal motility in an animal model of Lesch-Nyhan disease.

Authors:  Maria G Zizzo; Monica Frinchi; Domenico Nuzzo; Hyder A Jinnah; Giuseppa Mudò; Daniele F Condorelli; Francesco Caciagli; Renata Ciccarelli; Patrizia Di Iorio; Flavia Mulè; Natale Belluardo; Rosa Serio
Journal:  Auton Neurosci       Date:  2017-12-20       Impact factor: 3.145

Review 5.  Lesch-Nyhan Syndrome: Models, Theories, and Therapies.

Authors:  Scott Bell; Ilaria Kolobova; Liam Crapper; Carl Ernst
Journal:  Mol Syndromol       Date:  2016-09-24

6.  Purine metabolism during neuronal differentiation: the relevance of purine synthesis and recycling.

Authors:  Martin Göttle; Heike Burhenne; Diane Sutcliffe; H A Jinnah
Journal:  J Neurochem       Date:  2013-08-18       Impact factor: 5.372

7.  A model of behavioral treatments for self-mutilation behavior in Lesch-Nyhan syndrome.

Authors:  Eric A Zilli; Michael E Hasselmo
Journal:  Neuroreport       Date:  2008-03-05       Impact factor: 1.837

8.  Hypoxanthine-guanine phosphoribosyl transferase regulates early developmental programming of dopamine neurons: implications for Lesch-Nyhan disease pathogenesis.

Authors:  Irene Ceballos-Picot; Lionel Mockel; Marie-Claude Potier; Luce Dauphinot; Thomas L Shirley; Raoul Torero-Ibad; Julia Fuchs; H A Jinnah
Journal:  Hum Mol Genet       Date:  2009-04-02       Impact factor: 6.150

9.  Loss of dopamine phenotype among midbrain neurons in Lesch-Nyhan disease.

Authors:  Martin Göttle; Cecilia N Prudente; Rong Fu; Diane Sutcliffe; Hong Pang; Deborah Cooper; Emir Veledar; Jonathan D Glass; Marla Gearing; Jasper E Visser; H A Jinnah
Journal:  Ann Neurol       Date:  2014-06-20       Impact factor: 10.422

10.  Tetrahydrobiopterin deficiency and dopamine loss in a genetic mouse model of Lesch-Nyhan disease.

Authors:  K Hyland; S Kasim; K Egami; L A Arnold; H A Jinnah
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.